BiotechTube
Home/Viracta Therapeutics/John K. H. North
JK

John K. H. North

Former Chairman of the Board

Viracta Therapeutics

Therapeutic Areas

OncologyInfectious Disease (Virus-associated)

Viracta Therapeutics Pipeline

DrugIndicationPhase
Nanatinostat + Valganciclovir (Nana-val)Relapsed/Refractory EBV+ Lymphomas (PTCL, CTCL, DLBCL)Phase 2

Leadership Team at Viracta Therapeutics

DP
Darrel P. Cohen
Former Chief Medical Officer
IR
Ivor Royston
Former CEO, President, and Co-Founder
MR
Mark Rothera
Former President and CEO
DR
Daniel R. Chevallard
Former COO and CFO
View full Viracta Therapeutics profile